Experimental studies on mechanisms and treatments of brain edema in acute hepatic failure
Experimental studies on mechanisms and treatments of brain edema in acute hepatic failure
批准号:
04670422
负责人:
SUGIHARA Junichi
金额:
$1.22万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1992
资助国家:
日本
项目状态:
已结题
起止时间:
1992 至 1993
中文摘要
以肝性脑病血脑屏障(BBB)功能障碍为研究对象,探讨急性肝衰竭(AHF)模型脑水肿的发生机制及治疗方法。通过腹腔注射d -半乳糖胺盐酸盐(GalN)和脂多糖建立实验性AHF大鼠模型。1)随着肝性脑病病情的恶化,脑含水量逐渐升高。此外,根据Oldendorf法,AHF大鼠模型显示菊粉通过血脑屏障的通透性逐渐增加(约5200道尔顿)。2)在GalN和LPS处理后8、16、24小时静脉给予甘露醇,AHF大鼠模型脑水含量显著降低。然而,甘露醇的这种作用随着肝性脑病的进展而减弱,这是由于血脑屏障通透性和甘露醇脑浓度的升高。因此,甘露醇治疗脑水肿应在肝性脑病早期开始。3)前列腺素I_2(PGI_2)衍生物与前列腺素E_1(PG E_1)或生理盐水注射AHF大鼠模型相比,显著降低脑含水量和菊粉通过血脑屏障的通透性。PGI_2衍生物可以抑制血脑屏障的通透性,并保持血脑屏障的完整性,对AHF脑水肿有一定的影响。甘露醇联合PGI_2衍生物与单用甘露醇或PGI_2衍生物相比,能显著抑制AHF大鼠模型脑水肿的进展。PGI_2衍生物抑制甘露醇通过血脑屏障的渗透性,降低甘露醇在脑内的浓度。因此,甘露醇加PGI_2衍生物治疗AHF脑水肿更为有效。
英文摘要
Experimental studies were conducted to investigate the mechanisms and treatments of brain edema in acute hepatic failure(AHF) model, with special reference to functional disorders of the blood-brain barrier(BBB) in hepatic encephalopathy. The experimental AHF rat model was produced by intraperitoneal administration of D-galactosamine hydrochloride(GalN) and lipopolysaccaride.1) Brain water contents were gradually increased according to deterioration of hepatic encephalopathy. In addition, AHF rat model showed gradual increase of permeability of inulin(approximately 5,200 daltons) through the BBB by Oldendorf's method.2) Brain water contents in AHF rat model significantly decreased, when mannitol was administered intravenously at 8, 16, and 24 hours after treatment of GalN and LPS.However, this effect of mannitol weakened in parallel with progression of hepatic encephalopathy, due to the elevation of permeability through the BBB and brain concentration of mannitol. Therefore, mannitol treatment for brain edema should be started in earlier stage of hepatic encephalopathy.3) Prostaglandin I_2(PGI_2) derivative administration significantly decreased brain water contents and permeability of inulin through the BBB, when compared with prostaglandin E_1(PG E_1) or saline injected AHF rat model. PGI_2 derivative was considered to show the effect for brain edema in AHF, due to inhibition of BBB permeability and preservation of its integrity.Mannitol treatment together with PGI_2 derivative significantly inhibited the progression of brain edema in AHF rat model, when compared with mannitol or PGI_2 derivative alone, respectively. PGI_2 derivative inhibited the permeability of mannitol through BBB, and decreased mannitol concentration in brain. Therefore, administration of mannitol with PGI_2 derivative was considered to be more effective to brain edema in AHF.
期刊论文(48)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
杉原潤一: "劇症肝炎に対する肝移植の適応" Monthly Book of Gastro. 3(8). 33-40 (1993)
Junichi Sugihara:“暴发性肝炎的肝移植适应症”,《胃肠病杂志》3(8) (1993)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
杉原潤一: "劇症肝炎に対する血漿交換療法" 臨床消化器科. 18. 242-254 (1994)
Junichi Sugihara:“暴发性肝炎的血浆交换疗法”《临床胃肠病学》18. 242-254 (1994)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
加納 隆: "劇症肝炎における糖代謝異常に関する臨床的・基礎的検討" 肝臓. 33. 914-924 (1992)
Takashi Kano:“暴发性肝炎中糖代谢异常的临床和基础研究”肝脏 33. 914-924 (1992)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
F.Asano: "Enhanced production of leukotriene B_4 by peripheral blood mononuclear cells in patients with fulminant hepatitis" J.Gastroenterol.Hepatol.8. 228-231 (1993)
F.Asano:“暴发性肝炎患者外周血单核细胞白三烯 B_4 的产生增强”J.Gastroenterol.Hepatol.8。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
J.Sugihara: "The analysis of specific therapies for fulminant hepatic failure,in special relation to its clinical subtypes" Gastroenterol Jpn. 28. 623-623 (1993)
J.Sugihara:“暴发性肝衰竭的具体疗法分析,与其临床亚型有特殊关系”Gastroenterol Jpn。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 23 条
海外基金